CD274 and prostate carcinoma: These conflicting results underscore the complexity of PD‐L1 expression patterns in prostate cancer and highlight the need for further investigation to better understand its implications in the progression to castration resistance and the potential utility of PD‐L1‐targeted therapies in this subset of patients.